Odyssean LLC’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.31M Buy
65,463
+24,448
+60% +$1.9M 0.5% 61
2026
Q2
$3.05M Buy
+41,015
New +$2.87M 0.5% 46
2026
Q1
– Sell
-10,027
Closed -$767K – 428
2025
Q4
$767K Buy
+10,027
New +$658K 0.55% 8

Other funds holding BBIO

Odyssean LLC's BBIO Position: Q3 2026 in Review

Odyssean LLC increased its BridgeBio Pharma (BBIO) stake by 60% in Q3 2026, buying an estimated $1.9M and bringing the position to 65,463 shares worth $4.31M. The position accounts for 0.5% of the portfolio, ranked #61.

Odyssean LLC first reported a position in BBIO in Q4 2025 and has held it in 3 quarters since. 471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Odyssean LLC held 65,463 shares of BridgeBio Pharma worth $4.31M as of Q3 2026.
  • Odyssean LLC bought 24,448 BridgeBio Pharma shares in Q3 2026, an estimated $1.9M.
  • BridgeBio Pharma made up 0.5% of Odyssean LLC's portfolio in Q3 2026, its #61 holding.
  • Odyssean LLC first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 3 quarters since.
  • 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.